Product Code: 978-1-68038-856-5
The global alopecia market size is poised to reach USD 5.3 billion by 2027 and is anticipated to register a CAGR of 9.5% over the forecast period, according to a new report published by Grand View Research, Inc. Increasing prevalence of diseases across the globe, technological progress, and growth in per-capita expenditures toward healthcare are some of the factors expected to drive the market growth in the coming years.
There has been a marked increase in the overall disease prevalence due to changing lifestyle patterns such as surging consumption of tobacco and alcohol, unhealthy and inconsistent food habits, intense stress levels, and expanding geriatric population, thus contributing to the market growth. In addition, rising incidences of chronic diseases such as rheumatoid arthritis, cancer, and Polycystic Ovary Syndrome (PCOS) are anticipated to fuel the market growth.
The National Alopecia Areata Foundation stated that 147 million people are suffering from alopecia areata worldwide. Expanding consumer awareness towards this disease and possible treatments options are expected to augment the alopecia market growth. For instance, National Alopecia Areata Foundation's Treatment Development Program (TDP) has accelerated the research work pertaining to this condition.
Rogaine and Propecia remain the only FDA-approved products in this market. Patent expiration of branded drugs has expanded the generic penetration in this space. However, impending launch of multiple promising pipeline products, such as Xeljanz (tofacitinib), Jakafi (ruxolitinib), Breezula (clascoterone), SM04554, and Lumigan (Bimatoprost) is likely to inflate market growth in the near future.
Reimbursement for alopecia treatment continues to be a major challenge in this market. Most treatment modalities for this disorder are considered cosmetic and not medically essential, thus mostly remain uncovered under insurance schemes. Frequent doctor visits, coinsurance for procedures, and prescription drug copays are some of the major out-of-pocket costs for this disease treatment.
Further key findings from the study suggest:
The alopecia areata disease type segment contributed for over 30% of the revenue share in 2019
The androgenetic alopecia disease type segment is positioned to demonstrate a growth rate of over 10% over the forecast period
The homecare settings end-use segment is projected to be broadening penetration of laser treatment and rise in regulatory sanctions of home-use products
Asia Pacific is anticipated to witness the fastest growth owing to large population base and rising consumer awareness toward available treatment options
Economic betterment and increased per capita healthcare spending, in developing countries such as India, China, and Singapore are expected to boost the regional market
Lack of stringent reimbursement policies is a major factor restraining the market growth since the treatment for this disorder is not considered medically essential
Some of the key companies in the market of the key companies in the market are Johnson and Johnson Services, Inc.; Sun Pharmaceutical Industries Ltd.; Cipla Inc.; Lexington International LLC; Merck & Co., Inc.; Cirrus Hair Centers; and Transitions Hair Pty Ltd.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources & third party perspectives
- 1.3.4. Primary research
- 1.4. Information Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Alopecia Market Variables, Trends & Scope
- 3.1. Alopecia Market Lineage outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Regulatory Framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Increasing global prevalence of alopecia
- 3.4.1.2. Rise in global healthcare expenditure
- 3.4.1.3. Growing incidence of chronic diseases
- 3.4.1.4. Technological advancements in alopecia treatment
- 3.4.2. Market restraint analysis
- 3.4.2.1. Lack of reimbursement policies
- 3.5. Alopecia Market Analysis Tools
- 3.5.1. Industry analysis - Porter's
- 3.5.1.1. Supplier power: (Low due to large availability of products)
- 3.5.1.2. Buyer power: (High due to variety of options)
- 3.5.1.3. Substitution threat: (High due to replacements by transplantation)
- 3.5.1.4. Threat from new entrant: (High due to generic penetration)
- 3.5.1.5. Competitive rivalry: (High due to mergers & acquisitions by major players)
- 3.5.2. PESTEL analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Environmental landscape
- 3.5.2.3. Social landscape
- 3.5.2.4. Technology landscape
- 3.5.2.5. Legal landscape
- 3.5.3. Major deals & strategic alliances analysis
- 3.5.3.1. Joint ventures
- 3.5.3.2. Mergers & acquisitions
- 3.5.3.3. Licensing & partnership
- 3.5.3.4. Technology collaborations
- 3.5.3.5. Strategic divestments
Chapter 4. Alopecia Market: Disease Type Estimates & Trend Analysis
- 4.1. Definitions & Scope
- 4.2. Disease Type Market Share Analysis, 2019 & 2027
- 4.3. Alopecia Market, by Disease Type Type, 2015 to 2027
- 4.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
- 4.4.1. Alopecia areata
- 4.4.1.1 Alopecia areata market, 2015 - 2027 (USD Million)
- 4.4.2. Cicatricial alopecia
- 4.4.2.1 Cicatricial alopecia market, 2015 - 2027 (USD Million)
- 4.4.3. Traction alopecia
- 4.4.3.1 Traction alopecia market, 2015 - 2027 (USD Million)
- 4.4.4. Alopecia totalis
- 4.4.4.1 Alopecia totalis market, 2015 - 2027 (USD Million)
- 4.4.5. Alopecia universalis
- 4.4.5.1 Alopecia universalis market, 2015 - 2027 (USD Million)
- 4.4.6. Androgenetic alopecia
- 4.4.6.1 Androgenetic alopecia market, 2015 - 2027 (USD Million)
- 4.4.7. Others
- 4.4.7.1 Others alopecia market, 2015 - 2027 (USD Million)
Chapter 5. Alopecia Market: End Use Estimates & Trend Analysis
- 5.1. Definitions & Scope
- 5.2. End Use Market Share Analysis, 2019 & 2027
- 5.3. Alopecia Market, by End Use, 2015 to 2027
- 5.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
- 5.4.1. Dermatology clinics
- 5.4.1.1 Dermatology clinics market, 2015 - 2027 (USD Million)
- 5.4.2. Homecare setting
- 5.4.2.1 Homecare setting market, 2015 - 2027 (USD Million)
Chapter 6. Alopecia Market: Sales Channel Estimates & Trend Analysis
- 6.1. Definitions & Scope
- 6.2. Sales channel Market Share Analysis, 2019 & 2027
- 6.3. Alopecia Market, by Sales Channel, 2015 to 2027
- 6.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
- 6.4.1. Prescriptions
- 6.4.1.1 Prescriptions market, 2015 - 2027 (USD Million)
- 6.4.2. OTC
- 6.4.2.1 OTC market, 2015 - 2027 (USD Million)
Chapter 7. Alopecia Market: Gender Estimates & Trend Analysis
- 7.1. Definitions & Scope
- 7.2. Gender Market Share Analysis, 2019 & 2027
- 7.3. Alopecia Market, by Gender, 2015 to 2027
- 7.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
- 7.4.1. Male
- 7.4.1.1 Male alopecia market, 2015 - 2027 (USD Million)
- 7.4.2. Female
- 7.4.2.1 Female alopecia market, 2015 - 2027 (USD Million)
Chapter 8 Alopecia Market: Regional Estimates & Trend Analysis
- 8.1 Alopecia Market: Regional Movement Analysis, 2019 & 2027
- 8.2 Alopecia Market: Leading Players, 2019:
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
- 8.3 SWOT Analysis
- 8.3.1. North America
- 8.3.2. Europe
- 8.3.3. Asia Pacific
- 8.3.4. Latin America
- 8.3.5. Middle East & Africa
- 8.4 North America
- 8.4.1 North America Alopecia market, 2015 - 2027 (USD Million)
- 8.4.2 U.S.
- 8.4.2.1 U.S. Alopecia market, 2015 - 2027 (USD Million)
- 8.4.3 Canada
- 8.4.3.1 Canada Alopecia market, 2015 - 2027 (USD Million)
- 8.5. Europe
- 8.5.1 Europe Alopecia market, 2015 - 2027 (USD Million)
- 8.5.2 U.K.
- 8.5.2.1 U.K. Alopecia market, 2015 - 2027 (USD Million)
- 8.5.3 Germany
- 8.5.3.1 Germany Alopecia market, 2015 - 2027 (USD Million)
- 8.5.4 Spain
- 8.5.4.1 Spain Alopecia market, 2015 - 2027 (USD Million)
- 8.5.5 France
- 8.5.5.1 France Alopecia market, 2015 - 2027 (USD Million)
- 8.5.6 Italy
- 8.5.6.1 Italy Alopecia market, 2015 - 2027 (USD Million)
- 8.5.7 Sweden
- 8.5.7.1 Sweden Alopecia market, 2015 - 2027 (USD Million)
- 8.5.8 Netherlands
- 8.5.8.1 Netherlands Alopecia market, 2015 - 2027 (USD Million)
- 8.6 Asia Pacific
- 8.6.1 Asia Pacific Alopecia market, 2015 - 2027 (USD Million)
- 8.6.2 Japan
- 8.6.2.1 Japan Alopecia market, 2015 - 2027 (USD Million)
- 8.6.3 India
- 8.6.3.1 India Alopecia market, 2015 - 2027 (USD Million)
- 8.6.4 South Korea
- 8.6.4.1 South Korea Alopecia market, 2015 - 2027 (USD Million)
- 8.6.5 China
- 8.6.5.1 China Alopecia market, 2015 - 2027 (USD Million)
- 8.6.6 Australia
- 8.6.6.1 Australia Alopecia market, 2015 - 2027 (USD Million)
- 8.6.7 Taiwan
- 8.6.7.1 Taiwan Alopecia market, 2015 - 2027 (USD Million)
- 8.6.8 Vietnam
- 8.6.8.1 Vietnam Alopecia market, 2015 - 2027 (USD Million)
- 8.6.9 Thailand
- 8.6.9.1 Thailand Alopecia market, 2015 - 2027 (USD Million)
- 8.6.10 Malaysia
- 8.6.10.1 Malaysia Alopecia market, 2015 - 2027 (USD Million)
- 8.6.11 Singapore
- 8.6.11.1 Singapore Alopecia market, 2015 - 2027 (USD Million)
- 8.6.12 Indonesia
- 8.6.12.1 Indonesia Alopecia market, 2015 - 2027 (USD Million)
- 8.6.13 Philippines
- 8.6.13.1 Philippines Alopecia market, 2015 - 2027 (USD Million)
- 8.7 Latin America
- 8.7.1 Latin America Alopecia market, 2015 - 2027 (USD Million)
- 8.7.2 Brazil
- 8.7.2.1 Brazil Alopecia market, 2015 - 2027 (USD Million)
- 8.7.3 Mexico
- 8.7.3.1 Mexico Alopecia market, 2015 - 2027 (USD Million)
- 8.7.4 Argentina
- 8.7.4.1 Argentina Alopecia market, 2015 - 2027 (USD Million)
- 8.8 MEA
- 8.8.1 MEA Alopecia market, 2015 - 2027 (USD Million)
- 8.8.2 South Africa
- 8.8.2.1 South Africa Alopecia market, 2015 - 2027 (USD Million)
- 8.8.3 Turkey
- 8.8.3.1 Turkey Alopecia market, 2015 - 2027 (USD Million)
- 8.8.4 Egypt
- 8.8.4.1 Egypt Alopecia market, 2015 - 2027 (USD Million)
- 8.8.5 Iran
- 8.8.5.1 Iran Alopecia market, 2015 - 2027 (USD Million)
- 8.8.6 Israel
- 8.8.6.1 Israel Alopecia market, 2015 - 2027 (USD Million)
- 8.8.7 Saudi Arabia
- 8.8.7.1 Saudi Arabia Alopecia market, 2015 - 2027 (USD Million)
- 8.8.8 UAE
- 8.8.8.1 UAE Alopecia market, 2015 - 2027 (USD Million)
Chapter 9 Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Heat Map Analysis
- 9.3. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
- 9.4. Vendor Landscape
- 9.4.1. List of key distributors and channel partners
- 9.4.2. Key company market share analysis, 2019
- 9.5. Public Companies
- 9.5.1. Company market position analysis
- 9.5.2. Company Market Share
- 9.5.3. Competitive Dashboard Analysis
- 9.6. Private Companies
- 9.6.1. List of key emerging companies
- 9.6.2. Regional network map
- 9.6.3. Company market position analysis
- 9.7 Company Profiles
- 9.7.1 Cipla, Inc.
- 9.7.1.1 Company overview
- 9.7.1.2 Financial performance
- 9.7.1.3 Product benchmarking
- 9.7.1.4 Strategic initiatives
- 9.7.2 Sun Pharmaceuticals Industries Ltd.
- 9.7.2.1 Company overview
- 9.7.2.2 Financial performance
- 9.7.2.3 Product benchmarking
- 9.7.2.4 Strategic initiatives
- 9.7.3 Johnson & Johnson Services, Inc.
- 9.7.3.1 Company overview
- 9.7.3.2 Financial performance
- 9.7.3.3 Product benchmarking
- 9.7.3.4 Strategic initiatives
- 9.7.4 Merck & Co., Inc
- 9.7.4.1 Company overview
- 9.7.4.2 Financial performance
- 9.7.4.3 Product benchmarking
- 9.7.4.4 Strategic initiatives
- 9.7.5 Lexington Intl., LLC
- 9.7.5.1 Company overview
- 9.7.5.2 Financial performance
- 9.7.5.3 Product benchmarking
- 9.7.5.4 Strategic initiatives
- 9.7.6 Cirrus Hair Centers
- 9.7.6.1 Company overview
- 9.7.6.2 Financial performance
- 9.7.6.3 Product benchmarking
- 9.7.6.4 Strategic initiatives
- 9.7.7 Vita-Cos-Med Klett-Loch GmbH
- 9.7.7.1 Company overview
- 9.7.7.2 Financial performance
- 9.7.7.3 Product benchmarking
- 9.7.7.4 Strategic initiatives
- 9.7.8 Transitions Hair
- 9.7.8.1 Company overview
- 9.7.8.2 Financial performance
- 9.7.8.3 Product benchmarking
- 9.7.8.4 Strategic initiatives
- 9.7.9 Follica, Inc.
- 9.7.9.1 Company overview
- 9.7.9.2 Financial performance
- 9.7.9.3 Product benchmarking
- 9.7.9.4 Strategic initiatives
- 9.7.10 Capillus
- 9.7.10.1 Company overview
- 9.7.10.2 Financial performance
- 9.7.10.3 Product benchmarking
- 9.7.10.4 Strategic initiatives
